قراءات إضافية | الفيروسات: مقدمة قصيرة جدًّا

D. H. Crawford, The Invisible Enemy: A Natural History of Viruses (Oxford University Press, 2000).

B. La Scola, S. Audic, C. Robert, L. Jungang, X. De Lamballerie, M. Drancourt, R. Birtles, J. M. Claverie, and D. Raoult, ‘A Giant Virus in Amoebae’, Science, 299 (2003): 2033.
C. A. Suttle, ‘Viruses in the Sea’, Nature, 437 (2005): 356–61.
L. Ledford, ‘Death and Life Beneath the Sea Floor’, Nature, 545 (2008): 1038.
K. M. Oliver, P. H. Degnan, M. S. Hunter, and N. A. Moran, ‘Bacteriophages Encode Factors Required for Protection in a Symbiotic Mutualism’, Science, 325 (2009): 992–4.

P. Horvath and R. Barrangou, ‘CRISPR/Cas, the Immune System of Bacteria and Archaea’, Science, 327 (2010): 167–70.

A. J. McMichael, ‘Environmental and Social Influences on Emerging Infectious Diseases: Past, Present and Future’, Philosophical Transactions of the Royal Society, London B 359 (2004): 1049–58.
M. E. J. Woolhouse, ‘Population Biology of Emerging and Re-emerging Pathogens’, Trends in Microbiology, 10 (Suppl., 2002): S3–S7.

J. Diamond, Guns, Germs and Steel: A Short History of Everybody for the Last 13,000 Years (Vintage, 1998).
P. Aaby, ‘Is Susceptibility to Severe Infection in Low-Income Countries Inherited or Acquired?’, Journal of Internal Medicine, 261 (2007): 112–22.
P. Sharp and B. H. Hahn, ‘The Evolution of HIV-1 and the Origin of AIDS’, Philosophical Transactions of the Royal Society, London B, 2010.
J. F. Fears, ‘The Plague under Marcus Aurelius and the Decline and Fall of the Roman Empire’, Infectious Disease Clinics of North America, 18 (2004): 65–77.

D. A. Thorley-Lawson,‘Epstein-Barr Virus: Exploiting the Immune System’, Nature Reviews Immunology, 1 (2001): 75–82.

E. D. Pleasance et al., ‘A Comprehensive Catalogue of Somatic Mutations from a Human Cancer Genome’, Nature, 463 (2010): 191–6.
A. S. Evans and N. E. Mueller, ‘Viruses and Cancer: Causal Associations’, Annals of Epidemiology, 1 (1990): 71–92.

F. Fenner, D. A. Henderson, I. Arita et al., Smallpox and Its Eradication (WHO, Geneva, 1988).
A. J. Wakefield, S. H. Murch, A. Anthony et al., ‘Ileal-Lymphoid Nodular Hyperplasia, Non-Specific Colitis, and Pervasive Development Disorder in Children’, Lancet, 351 (1998): 637–41.
C. Dyer, ‘Lancet Retracts MMR Paper after GMC Finds Andrew Wakefield Guilty of Dishonesty’, British Medical Journal, 349 (2010): 281.
A. S. Fauci, ‘Pathogenesis of HIV Disease: Opportunities for New Preventive Interventions’, Clinical Infectious Diseases, 45 (Suppl. 4, 2007): S206–12.

D. H. Crawford, Deadly Companions: How Microbes Shaped Our History (Oxford University Press, 2007).
V. C. Lombardi et al., ‘Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome’, Science, 326 (2009): 585–9.
O. Erlwein et al., ‘Failure to Detect the Novel Retrovirus XMRV in Chronic Fatigue Syndrome’, PLoS ONE, 5 (2010): e8519.
S. Hacein-bey-Abina et al., ‘LMO2-associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1’, Science, 302 (2003): 415–19.